Mon. May 20th, 2024

Tty acid. a Multivariate adjustment for age at enrollment (continuous), race (white, black, other folks), CARET randomization assignment (retinol plus -carotene, placebo), loved ones history of prostate cancer in first-degree relatives (yes, no), alcohol consumption (nondrinker, under median, at or above median, unknown), smoking status (present, former/never), smoking pack-years (40, 40, 60, 60), and body mass index (continuous). b Defined as stage III/IV tumors or Gleason score 7.Am J Epidemiol. 2013;177(10):1106Table 5. Joint Associationa of Serum n-3 and n-6 Polyunsaturated Fatty Acids along with the MPO G-463A Polymorphism With Aggressive Prostate Cancerb in the Carotene and Retinol Efficacy Trial, 1985MPO c Genotype Quartile 1 No. of No. of Cases Controls 28 19 29 14 25 14 31 23 25 23 25 24 25 28 25 18 35 25 37 14 40 17 30 26 24 11 37 20 204 138 202 144 216 127 227 118 227 116 230 115 229 118 202 139 221 121 209 134 213 131 207 134 202 137 208 133 OR 95 CI Quartile 2 No. of No. of Cases Controls 39 25 27 23 31 23 26 26 40 24 30 19 32 19 39 ten 26 17 27 19 29 20 34 21 33 19 44 29 210 132 209 130 203 144 191 150 196 146 199 144 202 138 193 148 191 151 200 138 200 140 220 124 207 135 197 142 OR 95 CI Quartile three No. of No. of Circumstances Controls 27 19 33 23 37 22 38 15 29 15 38 19 35 14 32 23 37 16 38 21 31 18 36 21 33 24 21 19 189 156 197 145 197 146 206 137 206 139 200 143 201 142 197 146 196 147 194 151 207 132 204 139 207 142 203 142 OR 95 CI Quartile 4 No. of No. of Situations Controls 34 15 39 18 35 19 33 14 34 16 35 16 36 17 32 27 30 20 26 24 28 23 28 10 38 24 26 ten 217 123 212 130 204 132 196 144 191 148 191 147 188 151 228 116 211 130 217 126 one hundred 146 189 152 204 135 212 132 OR 95 CI Ptrend PinteractionFatty Acids n-3 PUFAs -Linolenic acid Eicosatrienoic acid Eicosapentaenoic acid Docosapentaenoic acid Docosahexaenoic acid EPA + DHA Total n-3 n-6 PUFAs Linoleic acid -Linolenic acid Eicosadienoic acid Dihomo– linolenic acid Arachidonic acid Docosadienoic acidGG GA/AA GG GA/AA GG GA/AA GG GA/AA GG GA/AA GG GA/AA GG GA/AA GG GA/AA GG GA/AA GG GA/AA GG GA/AA GG GA/AA GG GA/AA1.α-Glucosidase web Referent1.Cafestol References 31 0.PMID:27217159 77, two.22 1.45 0.80, two.61 0.92 0.52, 1.62 1.36 0.75, two.48 1.25 0.71, two.20 1.39 0.75, two.55 0.96 0.55, 1.69 1.28 0.73, two.26 1.88 1.09, 3.24 1.55 0.84, 2.84 1.39 0.79, 2.47 1.24 0.65, two.34 1.46 0.83, 2.56 1.32 0.70, two.51 1.61 0.93, 2.78 0.56 0.26, 1.20 0.78 0.45, 1.35 0.70 0.37, 1.30 0.74 0.43, 1.27 0.83 0.46, 1.52 0.76 0.45, 1.28 0.80 0.44, 1.43 1.11 0.65, 1.89 1.24 0.68, two.29 1.38 0.78, two.44 1.29 0.68, 2.47 1.31 0.81, two.14 1.19 0.69, two.1.08 0.61, 1.91 0.92 0.49, 1.71 1.18 0.69, 2.05 1.18 0.65, two.14 1.47 0.84, two.55 1.19 0.64, 2.22 1.34 0.80, two.25 0.83 0.43, 1.60 1.37 0.77, 2.45 1.05 0.53, two.08 1.74 1.01, three.02 1.25 0.66, two.38 1.64 0.94, two.87 0.92 0.46, 1.84 1.31 0.74, 2.30 1.27 0.69, 2.35 1.04 0.62, 1.74 0.61 0.32, 1.16 1.17 0.71, 1.93 0.80 0.45, 1.44 0.80 0.48, 1.34 0.74 0.40, 1.37 1.29 0.76, two.19 1.11 0.61, 2.03 1.44 0.81, two.54 1.50 0.81, two.77 0.60 0.34, 1.07 0.80 0.44, 1.1.16 0.67, 2.01 0.96 0.95 0.48, 1.87 0.80 1.39 0.82, 2.37 0.16 1.06 0.56, two.01 0.21 1.25 0.71, 2.20 0.27 1.11 0.58, two.14 0.95 1.21 0.71, two.06 0.24 0.72 0.37, 1.41 0.026 1.64 0.93, two.90 0.33 1.09 0.55, 2.15 0.17 1.66 0.95, two.92 0.07 1.06 0.54, 2.ten 0.15 1.70 0.97, 2.98 0.07 1.ten 0.56, two.14 0.033 1.22 0.69, two.16 0.96 2.04 1.16, three.74 0.017 0.78 0.46, 1.33 0.77 0.86 0.47, 1.56 0.07 0.68 0.39, 1.17 0.29 1.12 0.64, 1.99 0.06 0.73 0.43, 1.25 0.33 0.85 0.48, 1.51 0.66 1.03 0.59, 1.82 0.62 0.49 0.23, 1.07 0.